MASTER RESEARCH AND COLLABORATION AGREEMENT by and between VIVIDION THERAPEUTICS, INC. and CELGENE CORPORATION Dated as of March 1, 2018Master Research and Collaboration Agreement • June 25th, 2021 • Vividion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 25th, 2021 Company Industry JurisdictionThis Master Research and Collaboration Agreement (this “Agreement”) is entered into as of March 1, 2018 (the “Effective Date”) by and between Vividion Therapeutics, Inc., a Delaware corporation (“Vividion”) and Celgene Corporation, a Delaware corporation (“Celgene”). Celgene and Vividion are each referred to herein by name or as a “Party”, or, collectively, as the “Parties.”
MASTER RESEARCH AND COLLABORATION AGREEMENT by and between VIVIDION THERAPEUTICS, INC. and CELGENE CORPORATION Dated as of March 1, 2018Master Research and Collaboration Agreement • April 23rd, 2021 • Vividion Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 23rd, 2021 Company Industry JurisdictionThis Master Research and Collaboration Agreement (this “Agreement”) is entered into as of March 1, 2018 (the “Effective Date”) by and between Vividion Therapeutics, Inc., a Delaware corporation (“Vividion”) and Celgene Corporation, a Delaware corporation (“Celgene”). Celgene and Vividion are each referred to herein by name or as a “Party”, or, collectively, as the “Parties.”